Literature DB >> 28840482

Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.

C Requejo1, J A Ruiz-Ortega2, H Cepeda3, A Sharma4, H S Sharma3,4,5, A Ozkizilcik6, R Tian6,7, H Moessler8, L Ugedo2, J V Lafuente3,9,10.   

Abstract

Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson's disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6-hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine-induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotective-neurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD.

Entities:  

Keywords:  6-OHDA; Enriched environment; Nanowired cerebrolysin; Neuroprotection; Parkinson’s disease; Preclinical stage

Mesh:

Substances:

Year:  2018        PMID: 28840482     DOI: 10.1007/s12035-017-0741-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  70 in total

1.  Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro.

Authors:  Joshua L Fuqua; Ofelia M Littrell; Martin Lundblad; Jadwiga Turchan-Cholewo; Lina G Abdelmoti; Emilia Galperin; Luke H Bradley; Wayne A Cass; Don M Gash; Greg A Gerhardt
Journal:  Peptides       Date:  2014-01-07       Impact factor: 3.750

2.  Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Authors:  Ann D Cohen; Jennifer L Tillerson; Amanda D Smith; Timothy Schallert; Michael J Zigmond
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

3.  Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.

Authors:  C Requejo; J A Ruiz-Ortega; H Bengoetxea; A García-Blanco; E Herrán; A Aristieta; M Igartua; J L Pedraz; L Ugedo; R M Hernández; J V Lafuente
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

4.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

5.  Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.

Authors:  D Kirik; C Rosenblad; A Björklund
Journal:  Eur J Neurosci       Date:  2000-11       Impact factor: 3.386

6.  Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.

Authors:  Edward Rockenstein; Paula Desplats; Kiren Ubhi; Michael Mante; Jazmin Florio; Anthony Adame; Stefan Winter; Hemma Brandstaetter; Dieter Meier; Eliezer Masliah
Journal:  Stem Cell Res       Date:  2015-05-09       Impact factor: 2.020

7.  Intracellular signalling pathways in dopamine cell death and axonal degeneration.

Authors:  Robert E Burke
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 8.  Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease.

Authors:  Christina Mo; Anthony J Hannan; Thibault Renoir
Journal:  Neurosci Biobehav Rev       Date:  2015-03-10       Impact factor: 8.989

9.  Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology.

Authors:  Arne Herring; Mareike Blome; Oliver Ambrée; Norbert Sachser; Werner Paulus; Kathy Keyvani
Journal:  Brain Pathol       Date:  2009-01-07       Impact factor: 6.508

Review 10.  Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

Authors:  Ronald Deumens; Arjan Blokland; Jos Prickaerts
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  1 in total

1.  Enriched environment elevates expression of growth associated protein-43 in the substantia nigra of SAMP8 mice.

Authors:  Zhen-Yun Yuan; Jie Yang; Xiao-Wei Ma; Yan-Yong Wang; Ming-Wei Wang
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.